サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1411558

細胞シグナル伝達市場：製品タイプ別、最終用途別-2024-2030年の世界予測

Cell Signaling Market by Product (Consumables, Instruments), Type (Autocrine Signaling, Endocrine Signaling, Juxtacrine Signaling), End-use - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 185 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
細胞シグナル伝達市場：製品タイプ別、最終用途別-2024-2030年の世界予測
出版日: 2024年01月16日
発行: 360iResearch
ページ情報: 英文 185 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

細胞シグナル伝達市場規模は2023年に38億8,000万米ドルと推計され、2024年には41億2,000万米ドルに達し、CAGR 6.57%で2030年には60億6,000万米ドルに達すると予測されます。

細胞シグナル伝達の世界市場

主な市場の統計
基準年[2023］ 38億8,000万米ドル
予測年[2024］ 41億2,000万米ドル
予測年 [2030] 60億6,000万米ドル
CAGR（%） 6.57%
細胞シグナル伝達 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは細胞シグナル伝達市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、細胞シグナル伝達市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-細胞シグナル伝達市場の市場規模および予測は？

2-細胞シグナル伝達市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-細胞シグナル伝達市場における技術動向と規制の枠組みは？

4-細胞シグナル伝達市場における主要ベンダーの市場シェアは？

5-細胞シグナル伝達市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 生物医学調査活動における需要の増加
      • 細胞ベースの調査と治療を支援する政府の取り組み
      • 創薬と開発における細胞シグナル伝達の応用の拡大
    • 抑制要因
      • シグナル伝達経路と試薬開発に関連する複雑さ
    • 機会
      • 細胞シグナル伝達の技術とツールの継続的な進歩
      • 幹細胞調査活動への投資の増加
    • 課題
      • 細胞シグナル伝達に関連する倫理的問題と規制上の制約
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 細胞シグナル伝達市場：製品別

  • 消耗品
  • 機器

第7章 細胞シグナル伝達市場：タイプ別

  • 自己分泌シグナル伝達
  • 内分泌シグナル伝達
  • ジュクタクリンシグナル伝達
  • パラクリンシグナル伝達

第8章 細胞シグナル伝達市場：最終用途別

  • 学術・調査機関
  • 製薬およびバイオ医薬品産業

第9章 南北アメリカの細胞シグナル伝達市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の細胞シグナル伝達市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの細胞シグナル伝達市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第13章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Abcam PLC
    • Beckman Coulter, Inc. by Danaher Corporation
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Bio-Techne Corporation
    • BPS Bioscience, Inc.
    • Cell Biolabs, Inc.
    • Cell Signaling Technology, Inc.
    • Full Moon BioSystems, Inc.
    • Merck KGaA
    • Miltenyi Biotec B.V. & Co. KG
    • PerkinElmer Inc.
    • Promega Corporation
    • QIAGEN N.V.
    • RayBiotech Life, Inc.
    • Rockland Immunochemicals, Inc.
    • Santa Cruz Biotechnology, Inc.
    • Sino Biological, Inc.
    • StressMarq Biosciences Inc.
    • Thermo Fisher Scientific Inc.
  • 主要な製品ポートフォリオ

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. CELL SIGNALING MARKET RESEARCH PROCESS
  • FIGURE 2. CELL SIGNALING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. CELL SIGNALING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. CELL SIGNALING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. CELL SIGNALING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CELL SIGNALING MARKET DYNAMICS
  • FIGURE 7. CELL SIGNALING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. CELL SIGNALING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. CELL SIGNALING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 10. CELL SIGNALING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. CELL SIGNALING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 12. CELL SIGNALING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS CELL SIGNALING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS CELL SIGNALING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES CELL SIGNALING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES CELL SIGNALING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC CELL SIGNALING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC CELL SIGNALING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CELL SIGNALING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CELL SIGNALING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. CELL SIGNALING MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. CELL SIGNALING MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. CELL SIGNALING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. CELL SIGNALING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CELL SIGNALING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. CELL SIGNALING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. CELL SIGNALING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 9. CELL SIGNALING MARKET SIZE, BY AUTOCRINE SIGNALING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. CELL SIGNALING MARKET SIZE, BY ENDOCRINE SIGNALING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. CELL SIGNALING MARKET SIZE, BY JUXTACRINE SIGNALING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. CELL SIGNALING MARKET SIZE, BY PARACRINE SIGNALING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 14. CELL SIGNALING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. CELL SIGNALING MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL INDUSTRIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS CELL SIGNALING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES CELL SIGNALING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC CELL SIGNALING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA CELL SIGNALING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM CELL SIGNALING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM CELL SIGNALING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM CELL SIGNALING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 143. CELL SIGNALING MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 144. CELL SIGNALING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. CELL SIGNALING MARKET LICENSE & PRICING
目次
Product Code: MRR-007C484E5E6E

[185 Pages Report] The Cell Signaling Market size was estimated at USD 3.88 billion in 2023 and expected to reach USD 4.12 billion in 2024, at a CAGR 6.57% to reach USD 6.06 billion by 2030.

Global Cell Signaling Market

KEY MARKET STATISTICS
Base Year [2023] USD 3.88 billion
Estimated Year [2024] USD 4.12 billion
Forecast Year [2030] USD 6.06 billion
CAGR (%) 6.57%
Cell Signaling Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cell Signaling Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cell Signaling Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cell Signaling Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Beckman Coulter, Inc. by Danaher Corporation, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, BPS Bioscience, Inc., Cell Biolabs, Inc., Cell Signaling Technology, Inc., Full Moon BioSystems, Inc., Merck KGaA, Miltenyi Biotec B.V. & Co. KG, PerkinElmer Inc., Promega Corporation, QIAGEN N.V., RayBiotech Life, Inc., Rockland Immunochemicals, Inc., Santa Cruz Biotechnology, Inc., Sino Biological, Inc., StressMarq Biosciences Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Cell Signaling Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Consumables
    • Instruments
  • Type
    • Autocrine Signaling
    • Endocrine Signaling
    • Juxtacrine Signaling
    • Paracrine Signaling
  • End-use
    • Academic & Research Institutions
    • Pharmaceutical & Biopharmaceutical Industries
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cell Signaling Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cell Signaling Market?

3. What are the technology trends and regulatory frameworks in the Cell Signaling Market?

4. What is the market share of the leading vendors in the Cell Signaling Market?

5. Which modes and strategic moves are suitable for entering the Cell Signaling Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cell Signaling Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing demand in biomedical research activities
      • 5.1.1.2. Government initiatives supporting cell-based research and therapies
      • 5.1.1.3. Growing application of cell signaling in drug discovery and development
    • 5.1.2. Restraints
      • 5.1.2.1. Complexities associated with signaling pathways and reagent development
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in cell signaling techniques and tools
      • 5.1.3.2. Rising investment in stem cell research activities
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical issues and regulatory constraints associated with cell signaling
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Cell Signaling Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Instruments

7. Cell Signaling Market, by Type

  • 7.1. Introduction
  • 7.2. Autocrine Signaling
  • 7.3. Endocrine Signaling
  • 7.4. Juxtacrine Signaling
  • 7.5. Paracrine Signaling

8. Cell Signaling Market, by End-use

  • 8.1. Introduction
  • 8.2. Academic & Research Institutions
  • 8.3. Pharmaceutical & Biopharmaceutical Industries

9. Americas Cell Signaling Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cell Signaling Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cell Signaling Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Abcam PLC
    • 13.1.2. Beckman Coulter, Inc. by Danaher Corporation
    • 13.1.3. Becton, Dickinson and Company
    • 13.1.4. Bio-Rad Laboratories, Inc.
    • 13.1.5. Bio-Techne Corporation
    • 13.1.6. BPS Bioscience, Inc.
    • 13.1.7. Cell Biolabs, Inc.
    • 13.1.8. Cell Signaling Technology, Inc.
    • 13.1.9. Full Moon BioSystems, Inc.
    • 13.1.10. Merck KGaA
    • 13.1.11. Miltenyi Biotec B.V. & Co. KG
    • 13.1.12. PerkinElmer Inc.
    • 13.1.13. Promega Corporation
    • 13.1.14. QIAGEN N.V.
    • 13.1.15. RayBiotech Life, Inc.
    • 13.1.16. Rockland Immunochemicals, Inc.
    • 13.1.17. Santa Cruz Biotechnology, Inc.
    • 13.1.18. Sino Biological, Inc.
    • 13.1.19. StressMarq Biosciences Inc.
    • 13.1.20. Thermo Fisher Scientific Inc.
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing